Waverley Pharma Inc (WAVE) — Cash Flow-to-Debt Ratio
Waverley Pharma Inc (WAVE) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CA$-138.86K could theoretically repay 0% of its total liabilities (CA$3.64 Million) in one year. See Waverley Pharma Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Waverley Pharma Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Waverley Pharma Inc across 10 annual periods. Also explore Waverley Pharma Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Waverley Pharma Inc (2015–2024)
Year-by-year debt coverage analysis for Waverley Pharma Inc. For market capitalisation and broader financial context, see how much is Waverley Pharma Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.10x | CA$-410.19K | CA$4.08 Million | ▲ +79.4% |
| 2023 | -0.49x | CA$-1.02 Million | CA$2.09 Million | ▼ -229.1% |
| 2022 | -0.15x | CA$-237.06K | CA$1.60 Million | ▲ +64.8% |
| 2021 | -0.42x | CA$-798.78K | CA$1.89 Million | ▼ -68.9% |
| 2020 | -0.25x | CA$-361.70K | CA$1.45 Million | ▲ +72.6% |
| 2019 | -0.91x | CA$-1.41 Million | CA$1.55 Million | ▲ +20.6% |
| 2018 | -1.15x | CA$-1.45 Million | CA$1.26 Million | ▼ -1592.1% |
| 2017 | -0.07x | CA$-108.69K | CA$1.60 Million | ▲ +99.3% |
| 2016 | -9.27x | CA$-108.69K | CA$11.72K | ▲ +9.2% |
| 2015 | -10.21x | CA$-108.69K | CA$10.65K | — |